U.S. Specialty Stores Stock News

NYSE:ST
NYSE:STElectrical

Is It Too Late To Consider Sensata Technologies Holding (ST) After A 98% One Year Rally?

This article examines whether Sensata Technologies Holding, at around US$41.64, is priced for further upside or already reflects most of its story, focusing squarely on what the numbers indicate about value. The stock has returned 18.2% over the last 30 days and 97.8% over the past year. The year-to-date return is 19.3%, while the 5-year return is a 24.0% decline. Recent coverage has highlighted the stock's strong 1-year return of 97.8% and contrasted that with its weaker 5-year record. This...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Pharmaceutical (TEVA) Q1 EPS Of US$0.32 Tests Bullish Profitability Narrative

Teva Pharmaceutical Industries (TEVA) opened 2026 with Q1 revenue of US$3.98b and basic EPS of US$0.32, setting the tone for how its earnings story is evolving after a period marked by large one off items. Over recent quarters the company has seen revenue move from US$3.89b in Q1 2025 to US$4.71b in Q4 2025 before landing at US$3.98b in Q1 2026. Basic EPS moved from US$0.19 to US$0.42 and then to US$0.32 over the same stretch, giving you a clear view of how profitability per share has tracked...
NYSE:ASIC
NYSE:ASICInsurance

Ategrity Specialty Insurance (ASIC) Margins And 88.2% Combined Ratio Reinforce Bullish Underwriting Narrative

Ategrity Specialty Insurance Company Holdings (ASIC) kicked off Q1 2026 with total revenue of US$128.9 million and basic EPS of US$0.53, setting the tone for another data rich update for investors. Over the past four reported quarters, revenue has moved from US$83.1 million in Q1 2025 to US$128.9 million in Q1 2026, while basic EPS has shifted from US$0.02 to US$0.53, giving you a clear view of how the top and bottom lines have tracked together across the year. With trailing net profit...
NYSE:LII
NYSE:LIIBuilding

Why Lennox International (LII) Is Up 8.3% After Raising 2026 Revenue Outlook And Completing Buybacks

Lennox International recently reported past first-quarter 2026 results, posting US$1,135.1 million in sales versus US$1,072.6 million a year earlier, while maintaining full-year earnings guidance of US$23.50 to US$25.00 per share and updating revenue growth guidance to about 8%, partly reflecting benefits from completed acquisitions. Alongside these results, Lennox completed a long-running share repurchase program totaling 16.46 million shares for about US$3.32 billion, highlighting...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Solstice Advanced Materials Ties Halo Micro Reactor Fuel To Valuation Story

Hadron Energy and ConverDyn have agreed to use Solstice Advanced Materials’ uranium conversion facility to support the first commercial rollout of a new domestic Halo Micro-Modular Reactor. The partnership centers on creating a U.S. based fuel supply chain for advanced nuclear technologies. Solstice Advanced Materials, listed as NasdaqGS:SOLS, sits at the core of this arrangement as the conversion partner within the nuclear fuel cycle. For investors tracking the U.S. nuclear fuel...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

Is It Time To Reassess SEI Investments (SEIC) After Its Strong Recent Share Price Run?

Wondering if SEI Investments at around US$90.68 is offering fair value right now, or if the recent price leaves limited room for upside. The stock has been relatively steady over the last week with a 0.4% decline, but the 15.6% return over 30 days and 17.3% return over 1 year, alongside 62.4% over 3 years and 53.0% over 5 years, puts recent performance firmly on investors' radar. Recent coverage has focused on SEI Investments as an established player in capital markets services, with...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

A Look At Insmed (INSM) Valuation As Earnings Estimates And EPS Beat Expectations Improve

Recent earnings estimate revisions and expectations for an EPS beat have put fresh attention on Insmed (INSM), as investors weigh that optimism alongside the company’s upcoming healthcare conference presentations in May. See our latest analysis for Insmed. Insmed’s share price has recently pulled back, with a 30 day share price return of 16.63% and a year to date share price return decline of 23.03%. However, the 1 year total shareholder return stands at 87.68% and the 3 year total...
NYSE:GHC
NYSE:GHCConsumer Services

Graham Holdings (GHC) Margin Drop To 5.9% Tests Bullish Undervaluation Narrative

Graham Holdings (GHC) has put fresh numbers on the board for Q1 2026, with recent quarterly revenue running between about US$1.17 billion and US$1.28 billion over 2025 and Basic EPS ranging from US$5.50 to US$28.19 across those quarters. Over the past six reported quarters, revenue has moved from US$1,207.16 million in Q3 2024 to US$1,278.86 million in Q3 2025, while Basic EPS has ranged widely from US$16.55 to US$126.62. This has set the backdrop for a trailing net margin that has compressed...
NYSE:BR
NYSE:BRProfessional Services

Broadridge Financial Solutions (BR) Margin Improvement Reinforces Bullish Profitability Narratives

Broadridge Financial Solutions (BR) has put up another detailed scorecard for Q3 2026, with quarterly revenue of US$1.7 billion and basic EPS of US$2.44 sitting alongside trailing twelve month revenue of US$7.2 billion and EPS of US$9.12, set against one year earnings growth of 40.6%. Over the past five reported quarters, the company has seen revenue move from US$1.4 billion in Q1 2025 to US$1.7 billion in Q2 2026, while basic EPS shifted from US$0.68 to US$2.44. This frames the latest print...
NYSE:MTRN
NYSE:MTRNMetals and Mining

Is It Too Late To Consider Materion (MTRN) After A 119% One Year Rally?

Wondering if Materion, at a last close of US$183.81, still offers value or if most of the opportunity is already priced in? This article walks through the numbers so you can judge for yourself. The stock has returned 0.3% over the last 7 days, 27.1% over the last 30 days, 43.0% year to date and 119.3% over the past year, with longer term returns of 75.3% over 3 years and 145.9% over 5 years. These price moves sit against an ongoing flow of company and industry updates that can influence how...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Should CooperCompanies’ Upgraded 2026 Outlook and June 4 Earnings Call Shift COO’s Investment Narrative?

In April 2026, CooperCompanies said it would report its second-quarter 2026 results on June 4 and host a conference call to review financial performance and corporate developments for its CooperVision and CooperSurgical units. Analyst expectations for profit growth and management’s earlier decision to raise full-year 2026 guidance highlight how demand for premium contact lenses and fertility-related offerings is shaping current sentiment toward the business. With management’s upgraded...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

How Investors Are Reacting To Autohome (ATHM) Options Volatility And Trimmed Earnings Estimates

Recently, options activity in Autohome Inc. highlighted sharply higher implied volatility, signaling that traders expect a sizable move in the stock around a potential upcoming event. This options-driven uncertainty comes as analysts have trimmed earnings estimates and maintain a neutral rating, revealing a complicated mix of caution and anticipation around Autohome’s fundamentals. We’ll now examine how this spike in implied volatility and option activity could influence Autohome’s broader...
NYSE:ABR
NYSE:ABRMortgage REITs

Undervalued Small Caps With Insider Buying Opportunities In May 2026

In the last week, the United States market has stayed flat, but it has shown a robust 29% rise over the past 12 months with earnings forecasted to grow by 16% annually. In this environment, identifying small-cap stocks that are potentially undervalued and exhibit insider buying can offer intriguing opportunities for investors looking to capitalize on growth prospects.